Gordon LI, Liu FF, Braverman J, Hoda D, et al. Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study. Haematologica 2023 Aug 31. doi: 10.3324/haematol.2023.283162.
PMID: 37646670